Those with suspected recurrence based on elevated serum prostate-specific antigen level
The vote on BPC-157 reflected the unusual makeup of the panel
Who Epithalon May Be For Epithalon may be a fit for: Adults focused on structured longevity planning who want conservative, physician-led protocol design Individuals with persistent sleep dysregulation where broader evaluation has been considered People who want to pair peptide protocols with appropriate diagnostics and follow-up Who Should Be Cautious Epithalon may not be appropriate if: Sleep symptoms are new, severe, or rapidly worsening without evaluation There is untreated obstructive sleep apnea, severe mood disorder symptoms, or significant neurologic concerns that need assessment first The goal is anti-aging outcomes without willingness to address fundamentals (sleep hygiene, stress load, training recovery, metabolic factors) A peptide protocol should not become a substitute for proper evaluation

Common Risk Factors Several risk factors contribute to the development of hemorrhoids: Chronic Constipation or Diarrhea: Straining during bowel movements can increase pressure on the veins

Absorption differences: injection vs topical Subcutaneous injection absorption: Rapid absorption into bloodstream Peak plasma concentration: 15-30 minutes 80-90% bioavailability Reaches target tissues quickly Systemic distribution Topical application absorption: Slower penetration through skin barrier Peak tissue concentration: 1-3 hours 5-15% bioavailability (most doesn't penetrate) Primarily local effects (skin where applied) Minimal systemic exposure Absorption comparison table: Why injection more effective: Direct systemic delivery Reaches all tissues Predictable dosing Lower total dose needed Better for body-wide effects When topical makes sense: Face/neck cosmetic use only Avoiding injections Already using skincare routine Combining both approaches (injection + topical) See our GHK-Cu 50mg copper peptide dosage guide for injection protocols
The regulatory environment may also evolve